Results 231 to 240 of about 61,670 (295)

A Rare Combination of von Willebrand Disease Type 2A and 2M: Diagnostic and Therapeutic Challenges - A case report. [PDF]

Res Pract Thromb Haemost
Derikx F, Merry I, Willemsen D, Beckers E, Henskens Y, Heubel-Moenen F.   +5 more
europepmc   +1 more source

von Willebrand Factor and ADAMTS13 Predict Therapeutic Efficacy and Severe Adverse Events in Advanced Hepatocellular Carcinoma Treated With Atezolizumab–Bevacizumab

JGH Open, Volume 10, Issue 10, October 2026.
ABSTRACT Aims Atezolizumab combined with bevacizumab (AB therapy) is a standard first‐line treatment for advanced hepatocellular carcinoma (HCC). However, clinically useful biomarkers for predicting therapeutic efficacy and severe adverse events (AEs) remain limited.
Naoki Nishimura, Hiroaki Takaya, Tadashi Namisaki, Yusuke Komeda, Satoshi Iwai, Akihiko Shibamoto, Yuki Tsuji, Yukihisa Fujinaga, Koh Kitagawa, Shinya Sato, Norihisa Nishimura, Kosuke Kaji, Hitoshi Yoshiji   +12 more
wiley   +1 more source

Urgent Colectomy for Colonic Necrosis Following Shiga Toxin-Producing <i>Escherichia coli</i> O157 Infection in an Adult. [PDF]

Surg Case Rep
Baba K, Sumiyoshi T, Kobayashi T, Kondo Y, Tazuma S, Okano K, Muto T, Tatsumoto N, Takahashi S.   +8 more
europepmc   +1 more source

Pediatric Essential Thrombocythemia With a Novel CALR Mutation: A Case Report

eJHaem, Volume 7, Issue 5, October 2026.
ABSTRACT Pediatric essential thrombocythemia (ET) is extremely rare and frequently lacks identifiable driver mutations. We report a case of a 5‐year‐old male with ET harboring a novel CALR exon 9 frameshift mutation complicated by acquired von Willebrand syndrome.
Kana Tsuji, Suguru Uemura, Tomoko Fujikawa, Nobuyuki Yamamoto, Aiko Kozaki, Atsuro Saito, Toshiaki Ishida, Takeshi Mori, Makiko Yoshida, Takahiro Okutani, Daiichiro Hasegawa   +10 more
wiley   +1 more source

Measurement of Coagulation Factor Activity and Bacterial Growth in Canine and Feline Fresh Frozen Plasma With Unintended Exposure to Room Temperature. [PDF]

J Vet Emerg Crit Care (San Antonio)
Bilko SJ, Walker JM.
europepmc   +1 more source

2026 Asia Pacific Heart Rhythm Society (APHRS) Guidelines (Part II) on Stroke Prevention in Atrial Fibrillation

Journal of Arrhythmia, Volume 42, Issue 5, October 2026.
ABSTRACT The 2026 Asia Pacific Heart Rhythm Society (APHRS) Guidelines represent the first comprehensive APHRS guidelines dedicated to the management of atrial fibrillation (AF) and comprise four parts covering epidemiology, detection/screening and integrated care; stroke prevention; rate and rhythm control; and lifestyle risk factor and comorbidity ...
Tze‐Fan Chao, Gregory Y. H. Lip, Yi‐Hsin Chan, So‐Ryoung Lee, Mingfang Li, Daehoon Kim, Ling Kuo, Ken Okumura, Hung‐Fat Tse, Eue‐Keun Choi, Minglong Chen, Boyoung Joung, Rungroj Krittayaphong, Melissa E. Middeldorp, Kyoko Soejima, Hui‐Nam Pak   +15 more
wiley   +1 more source

Increased VWF-to-ADAMTS13 ratio is associated with large cerebral white matter hyperintensities. [PDF]

Blood Vessel Thromb Hemost
Story CM, Yanek L, Vaidya D, Brown J, Francischetti IMB, Nyquist P, Chaturvedi S.   +6 more
europepmc   +1 more source

Mouse models to study von Willebrand factor in inflammation: a scoping review. [PDF]

Intensive Care Med Exp
Masood H, DeYoung V, Andrisani P, Kodeeswaran A, Sparring T, Arora J, Savic N, Babulic JL, Matino D, Liaw PC, Kretz CA, Fox-Robichaud A.   +11 more
europepmc   +1 more source

Preoperative identification and multidisciplinary management of von Willebrand disease in atrial septal defect closure: a case report. [PDF]

Front Cardiovasc Med
Peng W, Wei Q, Yang J, Liu X.
europepmc   +1 more source

A NAC for Reducing vWF

The Hematologist, 2011
openaire   +1 more source